{
  "content": "Diagnosis:\nT2N1M0 Grade 2 invasive ductal carcinoma of right breast\nER positive (8/8), PR low positive (2/8), HER2 negative\nDiagnosed March 2024\n\nTreatment:\nWide local excision and sentinel node biopsy 15 April 2024\n3/12 nodes positive\nCommenced adjuvant FEC chemotherapy 10 May 2024\n\nCurrent situation:\nPre cycle 3 FEC chemotherapy\n\nCurrent symptoms:\nMild fatigue, grade 1 nausea well controlled with antiemetics\nNo significant mucositis\nNo peripheral neuropathy\n\nExamination:\nRight breast wound well healed\nNo lymphadenopathy\nPerformance status 1\n\nI reviewed [redacted name] today prior to cycle 3 FEC chemotherapy. She has tolerated the first two cycles reasonably well with only mild side effects as noted above. Her blood results today are satisfactory for proceeding with treatment. The surgical site continues to heal well with no concerns.\n\nPlan:\nProceed with cycle 3 FEC today\nContinue current antiemetic regime\nReview in 3 weeks for cycle 4",
  "output": {
    "primary_cancer": {
      "site": "breast, right",
      "year": 2024,
      "month": 3,
      "metastases": "3/12 lymph nodes positive",
      "tnm_stage": "T2N1M0",
      "histopathology_status": "Grade 2 invasive ductal carcinoma",
      "biomarker_status": "ER positive (8/8), PR low positive (2/8), HER2 negative",
      "cancer_timeline": [
        {
          "type": "treatment_surgery",
          "value": "Wide local excision and sentinel node biopsy with 3/12 nodes positive",
          "year": 2024,
          "month": 4
        },
        {
          "type": "treatment_systemic_start",
          "value": "Commenced adjuvant FEC chemotherapy",
          "year": 2024,
          "month": 5
        }
      ]
    },
    "patient_facts": [
      {
        "type": "current_symptom",
        "value": "Mild fatigue, grade 1 nausea well controlled with antiemetics"
      },
      {
        "type": "examination_finding",
        "value": "Right breast wound well healed, no lymphadenopathy"
      },
      {
        "type": "performance_status",
        "value": "Performance status 1"
      }
    ],
    "status_updates": [
      {
        "type": "clinical_summary",
        "value": "Early breast cancer post surgery, tolerating adjuvant FEC chemotherapy with minimal side effects"
      },
      {
        "type": "latest_treatment_toxicity",
        "value": "Grade 1 nausea, mild fatigue, no significant mucositis or peripheral neuropathy"
      },
      {
        "type": "update_to_treatment",
        "value": "Proceeding with cycle 3 FEC chemotherapy with current antiemetic regime"
      },
      {
        "type": "follow_up_referral",
        "value": "Review in 3 weeks for cycle 4"
      }
    ]
  }
}